mTOR Signaling in Parkinson's Disease (Q38855225)

7 September 2017

1 reference

title

mTOR Signaling in Parkinson's Disease (English)

1 reference

7 September 2017

1 reference

Ai-Ping Lan

1

1 reference

7 September 2017

Jun Chen

2

1 reference

7 September 2017

Yuliang Zhao

3

1 reference

7 September 2017

Zhifang Chai

4

1 reference

7 September 2017

Yi Hu

5

1 reference

7 September 2017

publication date

4 June 2016

1 reference

7 September 2017

published in

NeuroMolecular Medicine

1 reference

7 September 2017

volume

19

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

1-10

1 reference

Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

mTOR in Brain Physiology and Pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

MAPK and mTOR pathways are involved in cadmium-induced neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Corynoxine, a natural autophagy enhancer, promotes the clearance of alpha-synuclein via Akt/mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Autophagy deregulation in neurodegenerative diseases – recent advances and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Parkinson's disease: a complex interplay of mitochondrial DNA alterations and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

mTOR in aging, metabolism, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Autophagy and aging: the importance of maintaining "clean" cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Parkinson's disease: mechanisms and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Molecular Pathways of Neurodegeneration in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Pathogenic lysosomal depletion in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Mechanistic target of rapamycin complex 1 (mTORC1)-mediated phosphorylation is governed by competition between substrates for interaction with raptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Parkinson disease: from pathology to molecular disease mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Impairment of autophagy in the central nervous system during lipopolysaccharide-induced inflammatory stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

The role of local protein synthesis and degradation in axon regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Tnfaip8 l1/Oxi-β binds to FBXW5, increasing autophagy through activation of TSC2 in a Parkinson's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

The TSC1-TSC2 complex is required for proper activation of mTOR complex 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Ubiquitin hydrolase UCH-L1 destabilizes mTOR complex 1 by antagonizing DDB1-CUL4-mediated ubiquitination of raptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

TSC2 mediates cellular energy response to control cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

The growing role of mTOR in neuronal development and plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

NMNAT Expression and its Relation to NAD Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Neuroprotective Effect of Chebulagic Acid via Autophagy Induction in SH-SY5Y Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

High glucose condition induces autophagy in endothelial progenitor cells contributing to angiogenic impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Loss of autophagy in the central nervous system causes neurodegeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

mTOR signaling in growth control and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Molecular mechanisms of mTOR-mediated translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Programming apoptosis and autophagy with novel approaches for diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Oxidative stress: Biomarkers and novel therapeutic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

mTOR: on target for novel therapeutic strategies in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rheb fills a GAP between TSC and TOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Compromised autophagy and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Crosstalk Between Endoplasmic Reticulum Stress, Oxidative Stress, and Autophagy: Potential Therapeutic Targets for Acute CNS Injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

mTOR complex 2 signaling and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rapamycin protects against rotenone-induced apoptosis through autophagy induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

The rotenone model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rapamycin pre-treatment protects against apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Paraquat neurotoxicity is distinct from that of MPTP and rotenone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1/2 in H2O2-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Lithium induces autophagy by inhibiting inositol monophosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Erythropoietin and Wnt1 Govern Pathways of mTOR, Apaf-1, and XIAP in Inflammatory Microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Wnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern β-amyloid apoptotic injury of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Parkinson's Disease: Genetics and Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Mitochondria: the common upstream driver of amyloid-β and tau pathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Role of mTOR in physiology and pathology of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rapamycin inhibits mTORC1, but not completely.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

A guide to neurotoxic animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Pharmacologic agents targeting autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

α-Synuclein Is Degraded by Both Autophagy and the Proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Nicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from Pellagra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Paraquat, but Not Maneb, Induces Synucleinopathy and Tauopathy in Striata of Mice through Inhibition of Proteasomal and Autophagic Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Autophagy gone awry in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Onjisaponin B derived from Radix Polygalae enhances autophagy and accelerates the degradation of mutant α-synuclein and huntingtin in PC-12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Calcium signaling is involved in cadmium-induced neuronal apoptosis via induction of reactive oxygen species and activation of MAPK/mTOR network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Targets for neuroprotection in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Mapping autophagy on to your metabolic radar

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Nucleolar Disruption in Dopaminergic Neurons Leads to Oxidative Damage and Parkinsonism through Repression of Mammalian Target of Rapamycin Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Lysosomal membrane permeabilization in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Cooperative action of JNK and AKT/mTOR in 1-methyl-4-phenylpyridinium-induced autophagy of neuronal PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12017-016-8417-7

A trojan horse for Parkinson's disease

21 January 2018

1 reference

12 December 2020

Oxidative stress and diabetes mellitus

1 reference

12 December 2020

Pterostilbene simultaneously induces apoptosis, cell cycle arrest and cyto-protective autophagy in breast cancer cells

1 reference

12 December 2020

The economic and quality of life burden associated with Parkinson's disease: a focus on symptoms

1 reference

12 December 2020

Rapamycin protects the mitochondria against oxidative stress and apoptosis in a rat model of Parkinson's disease

1 reference

12 December 2020

mTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian rats

1 reference

12 December 2020

Systemic autophagy insufficiency compromises adaptation to metabolic stress and facilitates progression from obesity to diabetes

1 reference

12 December 2020

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

1 reference

12 December 2020

10.1007/S12017-016-8417-7

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1041779003

0 references

1 reference